SCHEMBL8429957

SCHEMBL8429957

N=C(CCC1CCCC1)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
ADAMTS4 O75173 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
AGER Q15109 1/20 0.38
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23709460 0.81 NPC1 (0.49) TDP1KMT2APOLBADAMTS4ADAMTS5
SCHEMBL2768439 0.79 TDP1 (0.59) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL2771673 0.73 TDP1 (0.56) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL19449767 0.72 TDP1 (0.46) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL17560915 0.72 TDP1 (0.55) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL17560912 0.72 TDP1 (0.55) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL17560918 0.72 TDP1 (0.55) TDP1ALDH1A1MEN1KMT2APOLB
SCHEMBL21726645 0.71 MAPT (0.44) ALDH1A1KMT2AKDM4ESMN1; SMN2TSHR
SCHEMBL21919220 0.71 SIGMAR1 (0.43) NPC1RAB9AMAOAMAOB
SCHEMBL21226652 0.70 LMNA (0.45) ALDH1A1POLBKDM4ESMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1643989-B1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS HOFFMANN LA ROCHE (CH) 2010-04-28 EP disclosed
US-20040259867-A1 CIS-imidazoles FOTOUHI NADER (US) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259867-A1 CIS-imidazoles TP53, MDM2, TP53BP1 TDP1 1038/4885ALDH1A1 1637/4885MEN1 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.